Diffuse neonatal hemangiomatosis treatment with cyclophosphamide: a case report.
We present 3-month-old male infant with diffuse neonatal hemangiomatosis. There were 63 cutaneous hemangiomas over the scalp, face, trunk, and extremities. Computed tomography scan revealed the presence of hemangiomas in the liver and kidneys; laryngobronchoscopy identified the presence of hemangioma in tracheobronchial tree. The child had symptoms of heart failure therefore digitals and diuretics were administrated. Thyroid functions were normal. Treatment with corticosteroids, in dose of 3 mg/kg/d intravenously, was initiated. As there was no significant clinical improvement, cyclophosphamide was administrated. He received 4 courses, 10 days apart. Each course consisted of 10 mg/kg/d of cyclophosphamide and 10 mg/kg/d of mesna for 4 consecutive days. After 4 cycles of cyclophosphamide, the liver was notably decreased in size and the cardiac failure was resolved. Magnetic resonance imaging of the abdomen revealed the marked decrease in size of the liver hemangioma. After 3 years of follow-up the child is well developed, fully recovered, without cardiologic or respiratory problems.
Vlahovic
Aleksandar
A
Division of Pediatric surgery, Department of Plastic Surgery and Burns, Institute for Mother and Child Health Care of Serbia, New Belgrade, Serbia. aleksandarvlahovic@yahoo.com
Simic
Radoje
R
Djokic
Dragomir
D
Ceran
Candemir
C
D018906:Antineoplastic Agents, Alkylating / Q000008:administration & dosage*; D003520:Cyclophosphamide / Q000008:administration & dosage*; D006391:Hemangioma / Q000188:drug therapy* / Q000473:pathology*; D006801:Humans; D007223:Infant; D008297:Male; D015080:Mesna / Q000008:administration & dosage*; D009928:Organ Specificity; D020011:Protective Agents / Q000008:administration & dosage*; D012074:Remission Induction
D018906:Antineoplastic Agents, Alkylating; D020011:Protective Agents; D003520:Cyclophosphamide; D015080:Mesna